BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
January 11, 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 19, 2023 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
December 14, 2023 08:30 ET
|
Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
April 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020
April 05, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
March 25, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
March 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
December 24, 2020 14:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc. Announces Launch of AEON™
October 27, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Oct. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...